Loading...
Loading...
NVNOW| Name | Value |
|---|---|
| Revenues | 0.0K |
| Cost of Revenue | 136.0K |
| Gross Profit | -136.0K |
| Operating Expense | 5,318.0K |
| Operating I/L | -5,454.0K |
| Other Income/Expense | 498.0K |
| Interest Income | 73.0K |
| Pretax | -4,956.0K |
| Income Tax Expense | 0.0K |
| Net Income/Loss | -4,956.0K |
enVVeno Medical Corporation, formerly known as Hancock Jaffe Laboratories, Inc., is a medical device company specializing in bioprosthetic tissue-based solutions for venous diseases. The company's lead product, the VenoValve, is a surgical implant designed to treat severe deep venous chronic venous insufficiency by restoring proper blood flow in the leg. The VenoValve is implanted in the femoral vein and acts as a one-way valve. enVVeno Medical Corporation generates revenue through the development and sale of its innovative medical devices, focusing on enhancing the standard of care in venous disease treatment.
